4-Methoxyphenyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyanoside>98.0%(HPLC)5g

n-(4-Bromo-2,5-difluoro-phenyl)-6-chloro-1h-pyrrolo[2,3-b]pyridine-3-sulfonamide, 98%, 250mg

2-Piperazin-1-yl-benzaldehyde, 95.0%, 1g

Tert-butyl 6-methyl-4-oxospiro[chromane-2,4'-piperidine]-1'-carboxylate, 98%, 250mg

3-Chlorobenzylamine, 97.0%, 10g

3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97%, 10g

1,3-Dimesityl-4,5-dihydro-1H-imidazol-3-ium tetrafluoroborate, 95%, 10g

N-Benzylglycine hydrochloride, 98.0%, 25g

(R)-Tetrahydro-2H-pyran-3-ol, 95.0%, 500mg

1-[(aminooxy)methyl]-4-chlorobenzene, 95.0%, 1g

Dodecylphosphocholine, 250mg

1,3-BIS(DICYANOMETHYLIDENE)INDAN, 98%, 25g

Anti-Human IgG Fc C-terminus Monoclonal Antibody1vial